These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 11694862)

  • 21. Effect of lercanidipine compared with ramipril on albumin excretion rate in hypertensive Type 2 diabetic patients with microalbuminuria: DIAL study (diabete, ipertensione, albuminuria, lercanidipina).
    Dalla Vestra M; Pozza G; Mosca A; Grazioli V; Lapolla A; Fioretto P; Crepaldi G
    Diabetes Nutr Metab; 2004 Oct; 17(5):259-66. PubMed ID: 16295047
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Microalbuminuria. An important marker for diabetic nephropathy and macrovascular disease].
    Bangstad HJ; Dahl-Jørgensen K; Aagenaes O; Hanssen KF; Kierulf P
    Tidsskr Nor Laegeforen; 1988 Sep; 108(26):2168-70. PubMed ID: 3206421
    [No Abstract]   [Full Text] [Related]  

  • 23. Microalbuminuria prevalence study (MAPS) in hypertensive patients with type 2 diabetes in Thailand.
    Buranakitjaroen P; Deerochanawong C; Bunnag P
    J Med Assoc Thai; 2005 Nov; 88(11):1624-9. PubMed ID: 16471111
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effects of spironolactone on nephron function in patients with diabetic nephropathy.
    Ustundag A; Tugrul A; Ustundag S; Sut N; Demirkan B
    Ren Fail; 2008; 30(10):982-91. PubMed ID: 19016150
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of high-dose vitamin E supplementation on oxidative stress and microalbuminuria in young adult patients with childhood onset type 1 diabetes mellitus.
    Giannini C; Lombardo F; Currò F; Pomilio M; Bucciarelli T; Chiarelli F; Mohn A
    Diabetes Metab Res Rev; 2007 Oct; 23(7):539-46. PubMed ID: 17266173
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The course of incipient diabetic nephropathy.
    Tindall H; Hopper AH; Davies JA
    Diabet Med; 1986 May; 3(3):282-3. PubMed ID: 2951188
    [No Abstract]   [Full Text] [Related]  

  • 27. Should albuminuria be a therapeutic target in patients with hypertension and diabetes?
    de Zeeuw D
    Am J Hypertens; 2004 Nov; 17(11 Pt 2):11S-15S; quiz A2-4. PubMed ID: 15539105
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Microalbuminuria].
    Iwai T; Uzu T
    Nihon Rinsho; 2010 Nov; 68 Suppl 9():401-5. PubMed ID: 21667493
    [No Abstract]   [Full Text] [Related]  

  • 29. Identification of urinary soluble E-cadherin as a novel biomarker for diabetic nephropathy.
    Jiang H; Guan G; Zhang R; Liu G; Cheng J; Hou X; Cui Y
    Diabetes Metab Res Rev; 2009 Mar; 25(3):232-41. PubMed ID: 19177462
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy.
    de Zeeuw D; Remuzzi G; Parving HH; Keane WF; Zhang Z; Shahinfar S; Snapinn S; Cooper ME; Mitch WE; Brenner BM
    Circulation; 2004 Aug; 110(8):921-7. PubMed ID: 15302780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reduction of albuminuria by angiotensin receptor blocker beyond blood pressure lowering: evaluation in megsin/receptor for advanced glycation end products/inducible nitric oxide synthase triple transgenic diabetic nephropathy mouse model.
    Ohtomo S; Ito M; Izuhara Y; Van Ypersele De Strihou C; Miyata T
    Nephrology (Carlton); 2008 Dec; 13(6):517-21. PubMed ID: 18363646
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evidence for a role of transforming growth factor (TGF)-beta1 in the induction of postglomerular albuminuria in diabetic nephropathy: amelioration by soluble TGF-beta type II receptor.
    Russo LM; del Re E; Brown D; Lin HY
    Diabetes; 2007 Feb; 56(2):380-8. PubMed ID: 17259382
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Detection of incipient diabetic nephropathy. Means of collecting urine and expressing results for the determination of microalbuminuria].
    Boulet-Thibaut A; Pennaforte S; Bordas-Fondrede N; Grimaldi A; Carayon A; Thervet F; Galli A
    Presse Med; 1987 Apr; 16(14):681-2. PubMed ID: 2952997
    [No Abstract]   [Full Text] [Related]  

  • 34. Urinary type IV collagen: a specific indicator of incipient diabetic nephropathy.
    Tan Y; Yang Y; Zhang Z; Zhang X; Zhang Z; Liu Y
    Chin Med J (Engl); 2002 Mar; 115(3):389-94. PubMed ID: 11940372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Microalbuminuria and its clinical significance.
    Shah SN; Gollapalli U
    J Assoc Physicians India; 1994 Oct; 42(10):767-8. PubMed ID: 7876042
    [No Abstract]   [Full Text] [Related]  

  • 36. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Microalbuminuria and early detection of diabetic nephropathy].
    Chachati A; Foidart-Willems J; Godon JP; Lefèbvre PJ
    Rev Med Liege; 1986 Feb; 41(4):117-21. PubMed ID: 3515482
    [No Abstract]   [Full Text] [Related]  

  • 38. Effect of indapamide SR on microalbuminuria--the NESTOR study (Natrilix SR versus Enalapril Study in Type 2 diabetic hypertensives with micrOalbuminuRia)--rationale and protocol for the main trial.
    Marre M; Garcia Puig J; Kokot F; Fernandez M; Jermendy G; Opie L; Moyseev V; Scheen A; Ionescu-Tirgoviste C; Saldanha MH; Halabe A; Williams B; Mion D; Ruiz M; Hermansen K; Tuomilehto J; Finizola B; Pozza G; Chastang C; Ollivier JP; Amouyel P; Asmar R
    J Hypertens Suppl; 2003 Mar; 21(1):S19-24. PubMed ID: 12769163
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Association of haptoglobin phenotypes with markers of diabetic nephropathy in Type 2 diabetes mellitus.
    Awadallah SM; Saleh SA; Abu Shaqra QM; Hilow H
    J Diabetes Complications; 2008; 22(6):384-8. PubMed ID: 18413152
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Is renoprotection by angiotensin receptor blocker dependent on blood pressure?: the Saitama Medical School, Albuminuria Reduction in Diabetics with Valsartan (STAR) study.
    Katayama S; Yagi S; Yamamoto H; Yamaguchi M; Izumida T; Noguchi Y; Inaba M; Inukai K
    Hypertens Res; 2007 Jun; 30(6):529-33. PubMed ID: 17664856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.